Tatva Chintan Pharma Chem Ltd.

₹1,150.2

-8.4 (-0.7%)

TATVA Share Price

Chemicals & Petrochemicals

As on March 13, 2026

SectorChemicals

IndustryChemicals & Petrochemicals

Basic IndustrySpecialty Chemicals

Market Cap₹ 2,690 Cr

P/E Ratio470.95

Dividend Yield0.01 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,142.14	Bullish
10-DMA	1,148.44	Bullish
20-DMA	1,180.97	Bearish
50-DMA	1,224.09	Bearish
100-DMA	1,325.92	Bearish
200-DMA	1,175.21	Bearish

Historical Performance

1 Year

80.6%

3 Years

-36.6%

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	3,827	3,935	4,236	4,336	3,004
Total Expenditure	3,483	3,251	3,628	3,251	2,337
Other Income	23	75	57	90	52
Operating Profit	368	759	665	1,175	719
Interest	15	67	86	52	44
Depreciation	277	256	96	82	67
Profit Before Tax	76	436	448	1,041	607
Consolidated Net Profit	57	304	455	959	523
Adjusted EPS	2	13	21	43	26

Compounded Sales Growth

10 Years:23.1

5 Years:7.8

3 Years:-2.5

TTM:-0.6

Compounded Profit Growth

10 Years:-15.2

5 Years:-31.5

3 Years:-43.1

TTM:-28.4

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:-13.9

TTM:80.6

Return on Equity

10 Years:N/A

5 Years:26

3 Years:20.5

last year:2.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	234	234	222	222	201
Total Reserves	7,154	7,137	4,926	4,509	1,459
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	-112	-103	-110	51	308
Other Current Liabilities	251	242	497	330	207
Short Term Borrowings	357	100	1,562	925	493
Total Liabilities	8,237	8,065	7,443	6,493	3,252
Capital Work in Progress	215	729	2,307	515	98
Long Term Loans & Advances	43	43	27	21	3
Currents Investments	---	101	---	---	---
Short Term Loans and Advances	283	203	173	267	202
Total Current Assets	2,653	2,980	3,141	4,356	1,946
Total Assets	8,237	8,065	7,443	6,493	3,252
Adjusted Book Value	316	315	232	213	83

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 470.95, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -13.9%, indicating poor shareholder returns.
The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹368 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹3827 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1799155.3

No. of Shares: 1564 (Approx)

Performance:79.9%

P/L: ₹799155.3

NIFTY Performance: 3.4%

1 day Top Gainers